FDA issued a Warning Letter to Promed Exports Private Limited on 8/9/2013 for a previous inspection.
483 Sentiss Pharma May 2017

483 Sentiss Pharma May 2017

$119 - Not in Stock

FDA investigators audited the Sentiss Pharma - District Solan, India facility and issued inspectional observations (via FDA 483) on 23 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 23 May 2017
  • Location: District Solan, India
  • FEI: 3008250236

Pre-Order Not Available